Natco Pharma gets EIR from USFDA for API facility in Hyderabad

01 Oct 2019 Evaluate

Natco Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, Hyderabad which was conducted during the period August 5-9, 2019.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

815.00 -16.75 (-2.01%)
27-Jan-2026 11:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.00
Dr. Reddys Lab 1240.45
Cipla 1304.65
Zydus Lifesciences 889.70
Lupin 2136.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×